Breakthrough sickle cell drug causes excitement
Clinical trials have shown that the one-time gene therapy, exagamglogene autotemcel (exa-cel), provides an effective cure in 96.6% of patients in addition to reducing pain completely and sickle cell crises/attacks.
PREMIUM Health
Dr. Charles Kiyaga, the head of sickle cell program at the Uganda’s Ministry of health. (Photos by John Musenze)
By NewVision Reporter
Journalists @NewVision
A groundbreaking sickle cell disease treatment has been approved for use in the UK's National Health Service (NHS). The treatment offers patients with severe forms